In this Cultivated News article, Shay Aaron Gilmore is quoted as a California cannabis and hemp business attorney providing expert analysis of a seismic federal development: the U.S. Drug Enforcement Administration’s move to begin accepting registration applications from a range of plant-touching businesses — including medical-cannabis manufacturers, growers, testing labs, and distributors — as part of the federal government’s shift to reschedule medical cannabis to Schedule III. The article captures Gilmore’s practical guidance for operators trying to understand what the new application process demands of them.
Gilmore’s central contribution is his analysis of the liability section of the DEA application, which he identifies as the portion requiring the most careful preparation. He walks through the four key questions the application poses — whether the applicant has ever been convicted of a controlled-substances crime under state or federal law; whether the applicant has ever surrendered for cause or had a federal controlled-substance registration revoked, suspended, restricted, or denied; whether the applicant has faced comparable actions against a state professional license or controlled-substance registration; and, for corporations, partnerships, and associations, whether any officer, partner, stockholder, or proprietor has faced such convictions or registration actions. Gilmore explains why these questions demand meticulous, truthful, and well-documented responses, given the stakes attached to a federal registration decision.
The article, informed by Gilmore’s counsel, also inventories the supporting documentation operators should expect to assemble: full standard operating procedures, training records and employee qualifications, quality-management and inventory-tracking and security systems, facility layouts and controls, audit reports (ideally with third-party certifications), active local and state permits, and complete corporate-structure and ownership charts. This checklist reflects the kind of rigorous, real-world preparation Gilmore advises clients to undertake.
The piece situates Gilmore among the practitioners the cannabis press turns to for authoritative, actionable analysis of federal policy shifts — consistent with the media page’s theme that leading legal and industry publications regularly seek his insight on regulatory developments. His quoted analysis helps operators understand not just that the DEA door has opened, but what it actually takes to walk through it compliantly.